Showing results (191-200 of 464) with videos related to
Sort By:
Pageof 47
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosisR D Meng, E R McDonald, M S Sheikh, et al.Cancer Biology & Therapy|August 13, 2002
BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiationRishu Takimoto, Timothy K MacLachlan, David T Dicker, et al.American Journal of Cancer Research|January 12, 2022
Chemotherapy-induced cytokines and prognostic gene signatures vary across breast and colorectal cancerLeya Groysman, Lindsey Carlsen, Kelsey E Huntington, et al.Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Integrin/TGF-β1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron pseudovirus infection of airway epithelial cells which could attenuate disease severityKelsey E Huntington, Lindsey Carlsen, Eui-Young So, et al.The Journal of Biological Chemistry|March 30, 2001
Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signalingE R McDonald, P C Chui, P F Martelli, et al.Cancer Biology & Therapy|December 30, 2009
Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-RasArunasalam Navaraj, Niklas Finnberg, David T Dicker, et al.Expert Opinion on Therapeutic Targets|September 25, 2012
Therapeutic targeting of the p53 pathway in cancer stem cellsVarun V Prabhu, Joshua E Allen, Bo Hong, et al.Biomolecules|April 23, 2022
Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in CancerShengliang Zhang, Lindsey Carlsen, Liz Hernandez Borrero, et al.Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
Sequence-specific transcriptional activation is essential for growth suppression by p53J A Pietenpol, T Tokino, S Thiagalingam, et al.Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease SeverityKelsey E Huntington, Lindsey Carlsen, Eui-Young So, et al.Pageof 47